Canadian Institutes of Health Research Evaluation Plan 2010/11 - 2014/15

[ Table of Contents ]

Appendices

Confirmation Note - From Treasury Board Guidance on Evaluation Plans

I submit to the Treasury Board of Canada Secretariat, the evaluation plan that I approved for the Canadian Institutes of Health Research for fiscal years 2010/11 - 2014/15, as required by the Policy on Evaluation (2009).

As per section 6.1.7 and 6.1.8 of the policy, I confirm that this five-year evaluation plan:

  1. Aligns with and supports the departmental Management, Resources and Results Structure;
  2. Has been designed to help support the requirements of the Expenditure Management System, including strategic reviews; and,
  3. Includes all ongoing programs of grants and contributions administered by CIHR, as required by section 42.1 of the Financial Administration Act. For some PAA categories, a purposive sampling approach has been taken to ensure coverage.

I will ensure that this plan is updated annually and will provide information about implementation of the evaluation plan to the Treasury Board of Canada Secretariat, as required.

Signature:

Dr. Alain Beaudet, President
Canadian Institutes of Health Research

List of CIHR stakeholders consulted for the 2010/11 - 2014/15 Evaluation Plan

Committees

  • CIHR Evaluation Committee (Executive Management Committee) - for final approval
  • Subcommittee on Performance Measurement - for advice and recommendations

Individuals

  • Dr. Alain Beaudet - President, CIHR
  • Christine Fitzgerald - Executive Vice President
  • Jim Roberge - Chief Financial Officer
  • Pierre Chartrand - Chief Scientific Officer
  • Ian Graham - Vice President, Knowledge Translation and Public Outreach
  • Joy Johnson - Scientific Director, Institute of Gender and Health
  • Michael Kramer - Scientific Director, Institute of Human Development, Child and Youth Health
  • Christian Sylvain - Director, Strategic Policy and External Relations
  • Peggy Borbey - Director, Knowledge Creation Programs
  • Terry Campbell - Director, PAN Institute Affairs and Initiatives
  • Jennifer O'Donoughue - Director, Health Research Roadmap Implementation Office
  • Danika Goosney - Director, Program Planning and Process
  • Michelle Gagnon - Director, Research Capacity Development
  • Kathryn Andrews-Clay - Director, Partnerships
  • Linda McKenzie - Director, Targeted Initiatives
  • Erica DiRuggiero - Associate Director, Institute of Population and Public Health
  • Paul Bélanger - Assistant Director, Institute of Nutrition, Metabolism and Diabetes
  • Laura McAuley - Manager, Impact Assessment
  • Bey Benhamadi - Manager, Data and Analysis
  • Kristiann Allen - Senior Ethics Policy Advisor
  • Sarah Viehbeck - Senior Evaluation Associate, Institute of Population and Public Health
  • Karen Wallace - Ethics Policy Advisor

CIHR Program Activity Architecture 2010-11

Vision

CIHR's vision is to position Canada as a world leader in the creation and use of knowledge through health research that benefits Canadians and the global community.

Mandate

The mandate of CIHR is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened health care system.

Strategic Outcome 1

A world-class health research enterprise that creates, disseminates and applies new knowledge across all areas of health research.

  • PA 1.1: Health Knowledge
    • SA 1.1.1: Open Research Grant Program
    • SA 1.1.2: Randomized Control Trials Program
       
  • PA 1.2: Health Researchers
    • SA 1.2.1: Salary Support Programs
      • SSA 1.2.1.1: Open Salary Support
      • SSA 1.2.1.2: Canadian Research Chairs Program
      • SSA 1.2.1.3: Canadian Excellence Research Chairs Program
         
    • SA 1.2.2: Training Support Programs
      • SSA 1.2.2.1: Open Training Support
      • SSA 1.2.2.2: Canadian Graduate Scholarships Program
      • SSA 1.2.2.3: Vanier Program
         
  • PA 1.3: Health Research Commercialization
    • SA 1.3.1: Research Commercialization Programs
    • SA 1.3.2: National Centres of Excellence Programs
      • SSA 1.3.2.1: Networks of Centres of Excellence
      • SSA 1.3.2.2: Business-led Networks of Centres of Excellence
      • SSA 1.3.2.3: Centres of Excellence for Commercialization and Research
         
  • PA 1.4: Health and Health Services Advances
    • SA 1.4.1: Institute Strategic Initiatives
      • SSA 1.4.1.1: Strategic Initiatives
      • SSA 1.4.1.2: Institute Support Grants
      • SSA 1.4.1.3: HIV/AIDS
      • SSA 1.4.1.4: Pandemic
      • SSA 1.4.1.5: National Anti-Drug Strategy Treatment Research Initiative
      • SSA 1.4.1.6: Strategy on Patient Oriented Research
      • SSA 1.4.1.7: Drug Safety and Effectiveness Networks
    • SA 1.4.2: Knowledge translation Programs
       
  • Internal Services

CIHR Program Activity Architecture 2009-10

Vision

CIHR's vision is to position Canada as a world leader in the creation and use of knowledge through health research that benefits Canadians and the global community.

Mandate

The mandate of CIHR is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened health care system.

Strategic Outcome 1.0: Canadian health research advances health knowledge and is responsive to current opportunities and priorities.

  • PA 1.1: Open Research
    • SA 1.1.1: Open Operating Grant
    • SA 1.1.2: Randomized Control Trials Program
    • SA 1.1.3: Team Grant Program
       
  • PA 1.2: Strategic Priority Research
    • SA 1.2.1: Strategic Priority Operating Grant Program
    • SA 1.2.2: Large Strategic Initiatives Program
    • SA 1.2.3: HIV/AIDS Research Initiative
    • SA 1.2.4: Pandemic Preparedness Research Initiative
    • SA 1.2.5: Expensive Drugs for Rare Diseases Research Initiative
    • SA 1.2.6: National Anti-Drug Strategy Treatment Research Initiative

Strategic Outcome 2.0: A strong and talented health research community with the capacity to undertake health research.

  • PA 2.1: Researchers and Trainees
    • SA 2.1.1: Salary Support Programs
    • SA 2.1.2: Training Support Programs
    • SA 2.1.3: Canada Research Chairs
    • SA 2.1.4: Canada Graduate Scholarships Program
    • SA 2.1.5: Strategic Salary Support
    • SA 2.1.6: Strategic Training Support
       
  • PA 2.2: Research Resources, and Collaborations
     
  • PA 2.3: National and International Partnerships
    • SA 2.3.1: Institute Support Grants
    • SA 2.3.2: Partnership Programs
       
  • PA 2.4: Ethical, Legal and Social Issues

Strategic Outcome 3.0: Health research is translated and adopted into practice, programs and policies that offer more effective health services and products, a strengthened health care system, and the improved health of Canadians.

  • PA 3.1: Knowledge Translation of Health Research
    • SA 3.1.1: Knowledge Translation Programs
    • SA 3.1.2: Networks of Centres of Excellence
       
  • PA 3.2: Commercialization of Health Research

CIHR PAA Crosswalk [2009-10 into 2010-11]

PAA Crosswalk - Program Activity Level
Integration of 2009-10 Program Activities into 2010-11 Program Activities
2010-2011 Program Activity 2009-2010 Program Activity
PA 1.1 Health Knowledge PA 1.1 Open Research
PA 2.2 Research Resources and Collaborations
PA 2.4 Ethical, Legal and Social Issues
PA l.2 Health Researchers PA 2.1 Researchers and Trainees
PA 1.3 Health Research Commercialization PA 3.2 Commercialization of Health Research
PA 1.4 Health and Health Services Advances PA 1.2 Strategic Priority Research
PA 2.3 National and International Partnerships
PA 3.1 Knowledge Translation of Health Research
PAA Crosswalk at the Sub-Activity Level
2010-2011 Sub-Activity 2009-2010 Program Activity/Sub-Activity
SA 1.1.1 Open Research Grant Program SA 1.1.1 Open Operating Grant Program
PA 2.2 Research Resources and Collaborations*
PA 2.4 Ethical, Legal and Social Issues*
SA 1.1.2 Randomized Control Trials (RCT) Program SA 1.1.2 Randomized Control Trials (RCT) Program
SA 1.2.1 Salary Support Programs SA 2.1.1 Salary Support Programs
SA 2.1.3 Canada Research Chairs
SA 1.2.2 Training Support Programs SA 1.1.3 Team Grant Program
SA 2.1.2 Training Support Programs
SA 2.1.4 CGS Program
SA 1.3.1 Research Commercialization Programs PA 3.2 Commercialization of Health Research*
SA 1.3.2 Networks of Centres of Excellence (NCE) Programs SA 3.1.2 Networks of Centres of Excellence (NCE) Program
SA 1.4.1 Institute Strategic Initiatives SA 1.2.1 SP Operating Grant Program
SA 1.2.2 Large Strategic Initiatives Program
SA 1.2.3 HIV/AIDS Research Initiative (RI)
SA 1.2.4 Pandemic Preparedness RI
SA 1.2.5 Expensive Drugs for Rare Diseases RI
SA 1.2.6 National Anti-Drug Strategy RI
SA 2.1.5 Strategic Salary Support
SA 2.1.6 Strategic Training Support
SA 2.3.1 Institute Support Grants
SA 1.4.2 Knowledge Translation Programs SA 2.3.2 Partnership Programs
SA 3.1.1 Knowledge Translation Program
* No sub-Activities related to this Program Activity  

Evaluation Unit
Strategy and Corporate Affairs Portfolio
Canadian Institutes of Health Research (CIHR)

160 Elgin Street, 8th Floor
Address Locator 4809A
Ottawa, Ontario
Canada K1A 0W9

Phone: 1-613-941-2672
Toll Free: 1-888-603-4178
Fax: 1-613-954-1800